Anika Therapeutics traded at $20.57 this Tuesday May 24th, decreasing $0.61 or 2.86 percent since the previous trading session. Looking back, over the last four weeks, Anika Therapeutics lost 8.56 percent. Over the last 12 months, its price fell by 53.13 percent. Looking ahead, we forecast Anika Therapeutics to be priced at 20.89 by the end of this quarter and at 19.38 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 113.75 -1.28 -1.11% -3.93%
Acorda Therapeutics 0.43 -0.06 -12.21% -88.68%
Agenus 1.50 -0.07 -4.46% -62.78%
Agios Pharmaceuticals 20.52 -0.57 -2.70% -63.74%
Anika Therapeutics 20.57 -0.61 -2.86% -53.13%
Arrowhead Research 34.85 -1.20 -3.33% -53.43%
ChemoCentryx 21.64 -0.73 -3.24% 120.54%
Clovis Oncology 0.63 -0.05 -8.02% -87.45%
Enanta Pharmaceuticals 42.72 0.25 0.58% -12.93%
Halozyme Therapeutics 44.11 -0.22 -0.50% 5.17%
Heron Therapeutics 3.22 -0.26 -7.47% -77.00%
Integra LifeSciences 60.14 -0.55 -0.91% -14.22%
Immunogen 3.42 -0.16 -4.34% -46.64%
Insmed 19.26 -0.75 -3.75% -24.05%
J&J 181.27 1.83 1.02% 6.58%
Karyopharm Therapeutics 5.70 -0.13 -2.23% -36.81%
Ligand Pharmaceuticals 80.53 -2.98 -3.57% -32.64%
MacroGenics 3.79 -0.17 -4.29% -87.37%
Merit Medical Systems 59.56 -1.00 -1.65% -5.76%
Peregrine Pharmaceuticals 12.16 0.05 0.37% -39.80%
Rigel Pharmaceuticals 1.90 -0.09 -4.29% -47.94%
Sanofi 103.38 -0.32 -0.31% 17.56%
Sangamo BioSciences 3.59 -0.42 -10.47% -66.39%
Smith & Nephew PLC 1,282.00 -6.00 -0.47% -17.56%
Surmodics 36.19 -0.76 -2.06% -33.28%
Stryker 233.17 0.12 0.05% -9.20%
Veracyte 17.04 -0.90 -5.02% -54.30%
Xencor 22.54 -0.21 -0.92% -42.54%
Intrexon 1.24 -0.01 -0.80% -81.04%
Zimmer Biomet Holdings Inc 120.15 -0.69 -0.57% -28.43%

Indexes Price Day Year
USND 11264 -270.83 -2.35% -17.52%
US2000 1765 -27.94 -1.56% -19.99%

Anika Therapeutics
Anika Therapeutics, Inc. is a joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. It is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. Its product categories include joint pain management therapies, joint preservation and restoration care, and Other. The joint pain management therapies offer injectable viscosupplement products that provide pain relief from osteoarthritis conditions and its products include MONOVISC, ORTHOVISC, CINGAL and HYVISC. Its joint preservation and restoration care products include HYALOFAST and TACTOSET. Its Other product family consists of Hyalobarrier and Hyaloglide.